Simplera is Medtronic’s first fully disposable continuous glucose monitor (CGM), FDA-cleared in late 2023. It is about 50 percent smaller than the Guardian Sensor 4, has a 30-minute warmup, and is worn for 7 days before the entire device is removed and replaced. There is no separate transmitter — the whole sensor is single-use, which is a major shift in Medtronic’s CGM strategy.
What Makes Simplera Different
For years, Medtronic CGMs required a reusable transmitter that snapped onto a disposable sensor. Users had to charge the transmitter, manage reorder cycles for two parts, and tape the bulky combination in place. Simplera collapses everything into one disposable device worn on the back of the upper arm — closer to the form factor of Dexcom G7 and FreeStyle Libre 3.
- Form factor: All-in-one disposable, about half the size of Guardian Sensor 4.
- Wear time: 7 days per sensor.
- Warmup: 30 minutes after insertion.
- Calibration: Factory-calibrated; no fingersticks required.
- Insertion: One-press disposable applicator.
How It Works
Like other CGMs, Simplera uses a thin filament inserted just under the skin to measure glucose in interstitial fluid (the fluid between cells, which tracks blood glucose closely with a 5-10 minute lag). The sensor measures glucose every minute and sends readings every 5 minutes via Bluetooth to a smartphone or compatible insulin pump.
Two versions exist:
- Simplera (standalone) — Pairs with the Simplera mobile app on iOS and Android for self-monitoring and trend data.
- Simplera Sync — FDA-cleared in 2024 to integrate with the Medtronic MiniMed 780G automated insulin delivery system, enabling closed-loop insulin dosing.
Accuracy
Accuracy is reported as MARD (mean absolute relative difference) — lower numbers mean closer to lab reference values. Pivotal studies submitted to the FDA show Simplera with an overall MARD of approximately 9 percent in adults. That is close to Dexcom G7 (around 8 percent) and FreeStyle Libre 3 (around 8 percent). All three sit comfortably within the accuracy needed to make insulin dosing and treatment decisions, per ADA guidance.
Practical tip: any CGM lags blood glucose during rapid changes. If a Simplera reading does not match symptoms (especially low blood sugar feelings), confirm with a fingerstick before treating.
Who Is Simplera For?
Simplera is approved for adults with diabetes (type 1 or type 2) age 7 and up. It is most attractive to:
- Current Medtronic 780G pump users who want a smaller, simpler sensor (use Simplera Sync).
- People starting on a Medtronic pump for the first time.
- Anyone with type 2 diabetes who wants real-time glucose trends and prefers Medtronic’s ecosystem and clinical support.
If you do not use a Medtronic pump, the trade-offs versus Dexcom G7 and Libre 3 are smaller. Insurance formulary, app preferences, and skin tolerance often decide. For broader context on CGM use in prediabetes and type 2, our prediabetes 101 hub provides a starting point.
Side Effects and Practical Notes
The most common issues across all CGMs are skin irritation under the adhesive, occasional sensor errors that cut wear short, and bumps or compression lows when sleeping on the sensor. Strategies that help:
- Rotate insertion sites and clean the skin before applying.
- Use a barrier wipe (Skin-Tac, IV Prep) if irritation appears, or hypoallergenic overlays.
- Keep the smartphone or pump within 20 feet for reliable Bluetooth.
- Acetaminophen does not affect Simplera readings (this was an issue on older Medtronic sensors).
Insurance and Cost
In the US, Simplera is covered under Medicare Part B for people meeting CGM criteria (insulin use plus a documented care plan), and most major commercial plans have added it to durable medical equipment formularies in 2024-2025. Out-of-pocket cost varies; ask your supplier or Medtronic’s support team for a coverage quote based on your plan. For complementary lifestyle measures that work alongside CGM data, see our diet and nutrition section.
The Bottom Line
The Simplera CGM is Medtronic’s first all-in-one disposable sensor — smaller, simpler, and 7-day wear. With the Sync version powering closed-loop insulin delivery on the 780G, it brings Medtronic in line with Dexcom and Abbott on form factor and convenience. According to the FDA, Simplera Sync is the latest sensor authorized for use with an automated insulin delivery system. Talk with your diabetes team about whether Simplera fits your devices, insurance, and routines.
